In vivo evaluation of A-56619 (difloxacin) and A-56620: new aryl-fluoroquinolones.

A-56619 and A-56620 are two new aryl-fluoroquinolones which are as potent as or more potent than norfloxacin when administered orally and subcutaneously in mouse protection tests against Staphylococcus aureus, Streptococcus pyogenes, and Streptococcus pneumoniae. A-56619 and A-56620 were more potent...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Päätekijät: Fernandes, P B, Chu, D T, Bower, R R, Jarvis, K P, Ramer, N R, Shipkowitz, N
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: 1986
Aiheet:
Research Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC176377/
https://ncbi.nlm.nih.gov/pubmed/3521473
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia